Abattis Bioceuticals Corp. Share Price Canadian Securities Exchange
Equities
ATT
CA00258G1037
Healthcare Facilities & Services
Sales 2018 | 8.37K 6.1K 509K | Sales 2019 | 357K 260K 21.71M | Capitalization | 8.62M 6.28M 524M |
---|---|---|---|---|---|
Net income 2018 | -78M -56.88M -4.74B | Net income 2019 | -3M -2.19M -182M | EV / Sales 2018 | 5,778 x |
Net cash position 2018 | 9.1M 6.63M 553M | Net cash position 2019 | 2.25M 1.64M 137M | EV / Sales 2019 | 17.8 x |
P/E ratio 2018 |
-0.57
x | P/E ratio 2019 |
-2.8
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 99.64% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | - | 01/19/01 | |
Patrick Mitchell
COO | Chief Operating Officer | - | 01/18/01 |
Jonathan Danieli
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Cedric Wilson
BRD | Director/Board Member | - | 19/18/19 |
Patrick Mitchell
COO | Chief Operating Officer | - | 01/18/01 |
Director of Finance/CFO | - | 01/19/01 |
1st Jan change | Capi. | |
---|---|---|
+46.09% | 284M | |
+30.93% | 270M | |
+53.49% | 198M | |
-28.99% | 146M | |
+56.76% | 142M | |
-28.57% | 120M | |
+140.12% | 140M | |
+3.85% | 89.69M | |
+150.00% | 75.33M |